Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Firefly Neuroscience (AIFF) over the last 14 years, with Q3 2025 value amounting to $86000.0.

  • Firefly Neuroscience's Capital Expenditures rose 205000.0% to $86000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $185000.0, marking a year-over-year increase of 17205.88%. This contributed to the annual value of $148000.0 for FY2024, which is N/A changed from last year.
  • Per Firefly Neuroscience's latest filing, its Capital Expenditures stood at $86000.0 for Q3 2025, which was up 205000.0% from $12000.0 recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's Capital Expenditures peaked at $301842.0 during Q4 2022, and registered a low of $4000.0 during Q3 2024.
  • Its 4-year average for Capital Expenditures is $61332.6, with a median of $18551.0 in 2021.
  • As far as peak fluctuations go, Firefly Neuroscience's Capital Expenditures skyrocketed by 209617.29% in 2022, and later tumbled by 8125.0% in 2025.
  • Firefly Neuroscience's Capital Expenditures (Quarter) stood at $13744.0 in 2021, then surged by 2096.17% to $301842.0 in 2022, then tumbled by 73.5% to $80000.0 in 2024, then increased by 7.5% to $86000.0 in 2025.
  • Its Capital Expenditures was $86000.0 in Q3 2025, compared to $12000.0 in Q2 2025 and $7000.0 in Q1 2025.